Interview: Navigating the clinical development space and sector-specific start-up challenges
Sam Whitaker was one of the founders of Greenphire, and CEO of multiple clinical trial technology companies including Mural Health.
Archives for May 4, 2023
Meaningful new treatment option for metastatic colorectal cancer from Taiho Oncology and Servier
Results from a multinational trial of trifluridine/tipracil, known as Lonsurf, with or without bevacizumab in refractory metastatic colorectal cancer (mCRC) have resulted in statistically significantly and clinically meaningful improvements.
Karyopharm encouraged by interim study results of blood cancer treatment, eltanexor
A single-agent treatment for patients with relapsed or refractory myelodysplastic neoplasms has shown promising results, including overall survival, in a study.